Status:
COMPLETED
Study of Automatic Image Fusion of a CT Volume With Ultrasound During Percutaneous Ablation Treatment of Hepatic Tumors
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
General Electric
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The automatic fusion of the ultrasound with a cone-beam CT volume will guide the positioning of the electrodes, despite the visibility of the tumor in ultrasound, in patients treated with irreversible...
Detailed Description
Percutaneous removal of hepatic tumours allows curative treatment using a range of techniques such as radiofrequency ablation, microwave, cryoablation or, more recently, irreversible electroporation. ...
Eligibility Criteria
Inclusion
- Age \>18 years
- Patient treated at Avicenna Hospital for HCC by irreversible electroporation (IRE)
- Patient whose tumor treatment requires the use of fusion tools with CBCT imaging at the beginning of the procedure
- Patients with a scheduled follow-up examination 1 month after the ablation procedure by irreversible electroporation (IRE)
- Patient who has understood the information and agreed to participate in this research by signing the consent form
- Patient affiliated to a social security system or entitled person
Exclusion
- Patients with a history of allergy to iodinated contrast material
- Patients with MRI contraindications
- Patients with a history of allergy to contrast material containing gadolinium
- Pregnant or breastfeeding women
- Patients under the protection of justice
- Patients unable to understand research information in an informed manner
- Participation in another interventional therapeutic trial
Key Trial Info
Start Date :
July 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2022
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04420026
Start Date
July 6 2020
End Date
July 29 2022
Last Update
October 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SERROR
Bobigny, France, 93000